Observed Signal · Oct 18, 2026 · Leadership Change · Source: PR Newswire: Technology News · Impact: 1/5 · Sentiment: Neutral
Lundbeck Chair Wenzel to Step Down; Novo's Jørgensen Succeeds
H. Lundbeck A/S announced that Dorothea Wenzel will step down as Chair of the Board at the 2027 Annual General Meeting. The Board intends to appoint Lars Fruergaard Jørgensen, former CEO of Novo Nordisk, as her successor. Jørgensen will join the Board as an observer on November 10, 2026, before formal election. This leadership transition aligns with Lundbeck's Focused Innovator strategy, moving into its Scale phase. Wenzel, who has served on the Board since 2021 and as Chair since March 2025, will leave after five years of involvement. Jørgensen brings over 30 years of pharmaceutical experience, including leading Novo Nordisk's growth in diabetes and obesity care.
Leadership change at a pharmaceutical company not directly related to advertising technology, marketing, or media.
Track Novo Nordisk Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Dorothea Wenzel will step down as Chair of Lundbeck's Board at the 2027 AGM.
- Lars Fruergaard Jørgensen, former CEO of Novo Nordisk, is intended to become new Chair.
- Jørgensen will join the Board as observer on November 10, 2026.
- Wenzel has been on the Board since 2021 and Chair since March 2025.
- Change is part of Lundbeck's Focused Innovator strategy entering its Scale phase.
Connected Companies & Entities
1 Entity mapped“Lars Fruergaard Jørgensen served as President and Chief Executive Officer of Novo Nordisk from 2017 to 2025...”
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Nestlé Names Antonia Wanner Head of Communications & Sustainability
Nestlé announced that Antonia Wanner will assume the combined role of Global Head of Corporate Communications and Sustainability and join the company’s Executive Committee effective 1 September 2026. The move merges the communications and sustainability functions under one leader; Nestlé said both areas will continue to operate their respective tasks operationally. Current communications chief Lisa Gibby will leave the role and return to the USA after six years. Nestlé’s spokesman and CEO Philipp Navratil said the closer alignment aims to strengthen dialogue with stakeholders (NGOs, regulators, policymakers and supranational organisations) and present external engagement more consistently. No job cuts are planned; roughly 70 people work in global communications and about 40 in global sustainability. Wanner has worked at Nestlé since 1996 and currently serves as Chief Sustainability Officer; she holds a doctorate in law.
Claudia Wolffgardt named Managing Director at dentsu X and MWO Health
Claudia Wolffgardt has been appointed Managing Director and Integrated Client Lead at dentsu X, effective immediately. She also assumes leadership of MWO Health, a brand of dentsu X, succeeding Linda-Maria Diodati, who left the agency earlier this year. This move follows the integration of MW Office into dentsu X, with MWO Health continuing as a specialized health communication brand. Wolffgardt will report to Andrea Biebl, President of iProspect, dentsu X, and MWO Health. Her role combines strategic consulting with expertise in media, creativity, customer experience, data, and technology, ensuring continuity in client relationships and strengthening collaboration between dentsu X and MWO Health. This promotion underscores dentsu's commitment to developing internal talent and is part of ongoing restructuring within dentsu Germany.
Receive all future signals for Novo Nordisk & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.